![Manher Joshi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Manher Joshi
Directeur Technique/Scientifique/R&D chez
RHYTHM PHARMACEUTICALS, INC.
Profil
Manher A. J.
Joshi is currently Chief Medical Officer at Rhythm Pharmaceuticals, Inc. since 2026.
Former positions include Head-US Medical Affairs at Allergan, Inc., Vice President-Medical Affairs & Operations at Genzyme Corp.
from 2005 to 2008, SVP-Strategic Development & Medical Operations at Synageva BioPharma Corp.
from 2008 to 2010, Chief Medical Officer & Executive Vice President at Atara Biotherapeutics, Inc. from 2018 to 2024, and Chief Development Officer at Soleno Therapeutics, Inc. from 2025 to 2026.
Education includes undergraduate studies at Boston University and a doctorate from Boston University School of Medicine.
Postes actifs de Manher Joshi
| Sociétés | Poste | Début |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 17/08/2026 |
Anciens postes connus de Manher Joshi
| Sociétés | Poste | Fin |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Corporate Officer/Principal | 15/05/2026 |
| ATARA BIOTHERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 02/02/2024 |
| SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | 01/07/2010 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/10/2008 |
| ALLERGAN, INC. | Corporate Officer/Principal | - |
Formation de Manher Joshi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Soleno Therapeutics, Inc.
 Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Boston University School of Medicine
 Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
